Capillary plasma elastase a1-proteinase inhibitor in infected and non-infected neonates

Capillary heel prick plasma elastase al-proteinase inhibitor (Ea,-PI) measured by an immunoassay (using commercially available reagents) was examined as an early indicator of neonatal sepsis. Fifty five infants were studied within 24 hours of birth; 60 (including 10 studied on the first day of life) were examined between two and 30 days after birth. Reference ranges for the neonatal period were developed. Raised Ea,-PI concentrations (range 440-2600 [ig/l) were found at the outset of each of the 24 infectious episodes including five with concomitant neutropenia. On the first day of life, obstetric and neonatal complications were also associated with high concentrations (range 190-2400 pg/ml). In infants who survived infection, Ea,-PI normalised with antibiotic treatment. It is concluded that capillary heel prick plasma is suitable for Eac-PI testing and raised concentrations provide a sensitive but non-specific index of infection in the first 24 hours after birth. Sequential testing may provide early warning of infectious complications and serve as a guide to the cessation of antibiotic treatment.

[1]  D. Tudehope,et al.  Early diagnosis of neonatal sepsis using a hematologic scoring system. , 1988, The Journal of pediatrics.

[2]  M. Struelens,et al.  Granulocyte elastase compared to C-reactive protein for early diagnosis of septicemia in critically Ill patients , 1988, European Journal of Clinical Microbiology and Infectious Diseases.

[3]  K. Radtke,et al.  Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections , 1987, European journal of haematology.

[4]  P. Hindocha,et al.  Sequential study of C reactive protein in neonatal septicaemia using a latex agglutination test. , 1984, Journal of clinical pathology.

[5]  R. Christensen,et al.  Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. , 1982, Pediatrics.

[6]  J. Hewitt,et al.  Early diagnosis of neonatal sepsis. , 1980, Pediatrics.

[7]  R. Christensen,et al.  Pitfalls in the interpretation of leukocyte counts of newborn infants. , 1979, American journal of clinical pathology.

[8]  C. Rosenfeld,et al.  The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. , 1979, The Journal of pediatrics.

[9]  S M Adler,et al.  The erythrocyte sedimentation rate in the newborn period. , 1975, The Journal of pediatrics.

[10]  K. Ohlsson,et al.  Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. , 1974, Scandinavian journal of clinical and laboratory investigation.

[11]  W. Grubb,et al.  Predicting neonatal infections by evaluation of the gastric aspirate: a study in two hundred and seven patients. , 1972, American journal of obstetrics and gynecology.

[12]  M. Gahr,et al.  Elastase-alpha 1-proteinase inhibitor: an early indicator of septicemia and bacterial meningitis in childhood. , 1988, Advances in experimental medicine and biology.

[13]  M. Jochum,et al.  Granulocyte proteinases as mediators of unspecific proteolysis in inflammation: a review. , 1986, Folia histochemica et cytobiologica.

[14]  S. Neumann,et al.  “PMN-Elastase Assay”: Enzyme Immunoassay for Human Polymorphonuclear Elastase Complexed with α1-Proteinase Inhibitor , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[15]  M. Jochum,et al.  Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. , 1984, Advances in experimental medicine and biology.

[16]  M. Jochum,et al.  Plasma levels of human granulocytic elastase-alpha1-proteinase inhibitor complex (E-alpha1PI) in patients with septicemia and acute leukemia , 1983 .